Skip to content

APC anti-human CD326 989938

by Biolegend, Inc.

APC anti-human CD326 989938 is an assay development analyte-specific reagent IVD (FDA Class I; FDA product code MVU, Reagents, Specific, Analyte) made by Biolegend, Inc., listed in FDA GUDID since 20 Aug 2026 (UDI-DI 00810034704221), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00810034704221 UDI-DI Date20 Aug 2026ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
URL: https://www.biolegend.com/en-gb/products/apc-anti-human-cd326-27591
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
APC anti-human CD326
Generic name
Assay development analyte-specific reagent IVD
Model / Ref / Catalog
989938
Primary DI / UDI-DI
00810034704221
FDA product code
MVU
GMDN term
Assay development analyte-specific reagent IVD
Device class
Class I
Regulation number
864.4020
GUDID distribution status
In Commercial Distribution
Size
Total Volume — 500 Microliter

Similar devices

Other devices filed under FDA product code MVU (Reagents, Specific, Analyte).

Other devices from Biolegend, Inc.

See all devices from Biolegend, Inc. →

Properties

  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)